Two Onc Docs

ASCO 2023 is just around the corner and we are teaming up with The Fellow On Call to bring you a joint mini-series called “Paging Heme/Onc: Updates from ASCO 2023” where we’ll bring you brief, high-yield discussions of some of the research we found most interesting from this year’s conference.

The podcast discusses indications for pre-transfusion protocols, infectious and non-infectious risks of transfusions, and acute & delayed risks. It also explores the management of transfusion reactions and serious complications like trolley and taco. Additionally, it covers anaphylactic reactions, post-transfusion perpura, transfusion graft-versus-host disease, infectious risks, and platelet refractoriness.

This week’s episode is part 1 of a 2 part series focusing on transfusion medicine. In part 1, we cover important details on blood group systems, blood components, indications for these components, and quickly cover apharesis. 

Explore the crucial steps in diagnosing thyroid cancer, staging, and treatments. Learn about the challenges of refractory thyroid cancer and targeted systemic therapies. Discover treatment options for anoplastic thyroid cancer and the significance of clinical trials. Delve into medullary thyroid cancer and targeted therapies for different cancer types.

This week’s episode is part 2 of our plasma cell dyscrasias series. We will go over the important details on risk stratification, as well as initial and relapse treatment options for Multiple Myeloma, with key details on the pharmacology of myeloma drugs.

This week’s episode will be an introduction to plasma cell dyscrasias. We will cover the diagnostic criteria for MGUS and Smoldering Myeloma as well as introduce Multiple Myeloma.

This podcast dives into inheritable bone marrow failure syndromes, covering the different types and their features, diagnosis, and treatment. Trilineage failures like Fanconi's anemia, dyskeratosis congenita, and gata2 deficiency are explored in detail. The discussion also includes marrow failure syndromes causing neutropenia and thrombocytopenia, highlighting their causes, presentations, and available treatment options.

Exploration of cholangiocarcinomas and gallbladder cancers, accurate imaging and biopsies for successful treatment, surgical resection, adjuvant therapy, alternative treatments, metastatic cholangiocarcinoma treatment options, targeted therapies, risk factors, primary sclerosis, colonitis, treatment regimens

Dive into the intriguing world of iron overload syndromes! Discover the complexities of hemochromatosis, from its symptoms like fatigue to severe complications, including heart failure. Learn about the critical role of early interventions such as phlebotomy in managing these conditions. Explore lesser-known syndromes like Bantu syndrome and the necessity for iron chelation therapy. This is a fascinating journey through genetic factors, diagnostic methods, and patient care strategies—the hidden side of iron overload!

The hosts reflect on the one year anniversary of their podcast, sharing stories of how they met and became friends. They discuss the rewarding career path to becoming an oncologist or hematologist, including the necessary steps and education required. They also explore the requirements for entering medical school and the process of completing medical school and applying for a residency program. The chapter also covers becoming an oncologist after residency, including fellowships, sub-specialization, and the job hunt. Lastly, an overview of career paths in hematology oncology, including academia, community practice, and industry roles.